IRIS Accounts Production v23.3.1.45 SC156102 Board of Directors 1.4.22 31.3.23 31.3.23 20.10.23 false true false false true false Auditors Opinion Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC1561022022-03-31SC1561022023-03-31SC1561022022-04-012023-03-31SC1561022021-03-31SC1561022021-04-012022-03-31SC1561022022-03-31SC156102ns16:Scotland2022-04-012023-03-31SC156102ns15:PoundSterling2022-04-012023-03-31SC156102ns11:Director12022-04-012023-03-31SC156102ns11:PrivateLimitedCompanyLtd2022-04-012023-03-31SC156102ns11:SmallEntities2022-04-012023-03-31SC156102ns11:Audited2022-04-012023-03-31SC156102ns11:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-31SC156102ns11:SmallCompaniesRegimeForAccounts2022-04-012023-03-31SC156102ns11:FullAccounts2022-04-012023-03-31SC156102ns11:OrdinaryShareClass12022-04-012023-03-31SC156102ns11:Director22022-04-012023-03-31SC156102ns11:Director32022-04-012023-03-31SC156102ns11:Director42022-04-012023-03-31SC156102ns11:CompanySecretary12022-04-012023-03-31SC156102ns11:RegisteredOffice2022-04-012023-03-31SC156102ns6:CurrentFinancialInstruments2023-03-31SC156102ns6:CurrentFinancialInstruments2022-03-31SC156102ns6:ShareCapital2023-03-31SC156102ns6:ShareCapital2022-03-31SC156102ns6:RetainedEarningsAccumulatedLosses2023-03-31SC156102ns6:RetainedEarningsAccumulatedLosses2022-03-31SC156102ns6:LandBuildings2022-03-31SC156102ns6:FurnitureFittings2022-03-31SC156102ns6:LandBuildings2022-04-012023-03-31SC156102ns6:FurnitureFittings2022-04-012023-03-31SC156102ns6:LandBuildings2023-03-31SC156102ns6:FurnitureFittings2023-03-31SC156102ns6:LandBuildings2022-03-31SC156102ns6:FurnitureFittings2022-03-31SC156102ns6:WithinOneYearns6:CurrentFinancialInstruments2023-03-31SC156102ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-31SC156102ns11:OrdinaryShareClass12023-03-31
REGISTERED NUMBER: SC156102 (Scotland)









Financial Statements

for the Year Ended 31 March 2023

for

DORNOCH MEDICAL CARE LIMITED

DORNOCH MEDICAL CARE LIMITED (REGISTERED NUMBER: SC156102)

Contents of the Financial Statements
FOR THE YEAR ENDED 31 MARCH 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


DORNOCH MEDICAL CARE LIMITED

Company Information
FOR THE YEAR ENDED 31 MARCH 2023







DIRECTORS: L Blackwood
S Clarke-Kuehn
C J Moule
N Seymour





SECRETARY: N Seymour





REGISTERED OFFICE: Sanctuary House
7 Freeland Drive
Glasgow
G53 6PG





REGISTERED NUMBER: SC156102 (Scotland)





AUDITORS: Haines Watts Bristol Limited
Chartered Accountants and Statutory Auditors
Bath House
6 - 8 Bath Street
Bristol
BS1 6HL

DORNOCH MEDICAL CARE LIMITED (REGISTERED NUMBER: SC156102)

Balance Sheet
31 MARCH 2023

2023 2022
Notes £    £   
FIXED ASSETS
Tangible assets 4 1,300,810 1,099,234

CURRENT ASSETS
Debtors 5 71,404 91,394
Cash at bank and in hand 1,161,734 1,260,694
1,233,138 1,352,088
CREDITORS
Amounts falling due within one year 6 (1,641,432 ) (1,537,179 )
NET CURRENT LIABILITIES (408,294 ) (185,091 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

892,516

914,143

PROVISIONS FOR LIABILITIES (35,732 ) (35,135 )
NET ASSETS 856,784 879,008

CAPITAL AND RESERVES
Called up share capital 7 110,000 110,000
Retained earnings 746,784 769,008
SHAREHOLDERS' FUNDS 856,784 879,008

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved and authorised for issue by the Board of Directors and authorised for issue on 20 October 2023 and were signed on its behalf by:





L Blackwood - Director


DORNOCH MEDICAL CARE LIMITED (REGISTERED NUMBER: SC156102)

Notes to the Financial Statements
FOR THE YEAR ENDED 31 MARCH 2023


1. COMPANY INFORMATION

Dornoch Medical Care Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The company's principal activities and nature of its operations are disclosed in the Directors' Report.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" ("FRS 102") and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared on the historical cost convention. The principal accounting policies adopted are set out below.

Going concern
The financial statements have been prepared on a going concern basis. The directors have reviewed and considered relevant information including the annual budget and future cash flows in making their assessment on their business. Based on these assessments, given the measures that could be undertaken to mitigate the current adverse conditions, and the current resources available, the directors have concluded that they can continue to adopt the going concern basis in preparing the annual report and accounts.

Significant judgements and estimates
In the application of the company's accounting policies, management are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are outlined below.

The amount of debts which are provided for is based on a percentage basis. Factors to determine this percentage include the funding source and the customer payment history. At 31 March 2023, £1,992 (2022 - £3,570) was provided for in respect of bad debts.

Revenue is deferred where it relates to residents' stays in the next financial period. This is calculated based on the proportion of income received relating to the period of stay in the next financial period. At 31 March 2023, £14,579 (2022 - £5,882) of income has been deferred based on this estimate.

Tangible assets are depreciated or amortised on the useful life of each category of asset. Estimates are made when determining the useful life of the asset. For the period ended 31 March 2023, depreciation of £122,650 (2022 - £49,890) was recognised.

Turnover
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services provided in the normal course of business and is recognised on a time apportioned basis.

DORNOCH MEDICAL CARE LIMITED (REGISTERED NUMBER: SC156102)

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MARCH 2023


2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost, less estimated residual value, of each asset on a systematic basis over its expected useful life as follows:

Freehold landNil
Freehold buildings25-50 years
Furniture, plant and equipment5 years

Cash and cash equivalents
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets, which include trade and other debtors, and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost. Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Basic financial liabilities, including trade and other creditors are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. Financial liabilities are derecognised when, and only when, the company's contractual obligations are discharged, cancelled, or they expire.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the income statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


DORNOCH MEDICAL CARE LIMITED (REGISTERED NUMBER: SC156102)

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MARCH 2023


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Provisions
Provisions are recognised when the company has an obligation at the balance sheet date as a result of a past event, it is probable that an outflow of economic benefits will be required in settlement and the amount can be reliably estimated.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 60 (2022 - 68 ) .

4. TANGIBLE FIXED ASSETS
Furniture,
Freehold plant &
property equipment Totals
£    £    £   
COST
At 1 April 2022 1,258,474 557,727 1,816,201
Additions 223,721 63,867 287,588
At 31 March 2023 1,482,195 621,594 2,103,789
DEPRECIATION
At 1 April 2022 333,977 382,990 716,967
Charge for year 32,399 53,613 86,012
At 31 March 2023 366,376 436,603 802,979
NET BOOK VALUE
At 31 March 2023 1,115,819 184,991 1,300,810
At 31 March 2022 924,497 174,737 1,099,234

Included in cost of land and buildings is freehold land of £ 240,000 (2022 - £ 240,000 ) which is not depreciated.

Also included in the cost of land and buildings is the residual amount of £414,103 which also includes car park land. These amounts are non-depreciable.

DORNOCH MEDICAL CARE LIMITED (REGISTERED NUMBER: SC156102)

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MARCH 2023


5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 50,433 53,543
Prepayments and accrued income 20,971 37,851
71,404 91,394

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 63,581 127,264
Amounts owed to participating interests 1,182,042 1,154,287
Other creditors 147,714 17,600
Deferred income 14,579 5,882
Accrued expenses 233,516 232,146
1,641,432 1,537,179

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
110,000 Ordinary £1 110,000 110,000

8. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Matthew Bracher BSc FCA (Senior Statutory Auditor)
for and on behalf of Haines Watts Bristol Limited

9. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The
Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party
transactions with the parent company.

10. ULTIMATE CONTROLLING PARTY

The company is a wholly owned subsidiary of Sanctuary Housing Association, a registered society incorporated in England and Wales. Group accounts may be obtained from the registered office at Chamber Court, Castle Street, Worcester, WR1 3ZQ.